Detect and Prevent Infections Early with Reliable Blood Testing

Infectious disease tests identify bacteria, viruses, or other harmful organisms in the body. Bids Chemist offers discreet and accurate testing for common infections. Early detection ensures timely treatment, prevents complications, and helps protect both your health and the wellbeing of those around you. 

This test detects adenovirus genetic material using polymerase chain reaction (PCR), a highly sensitive method to identify viral infections. Adenoviruses can cause respiratory infections, conjunctivitis, gastroenteritis, or systemic illness, particularly in children or immunocompromised individuals. Samples can be taken from blood, throat, or swabs from affected areas. PCR amplifies the virus’s genetic material, allowing precise detection even in early infection. Rapid identification helps healthcare providers implement timely treatment, manage symptoms, and prevent further transmission. Knowing whether adenovirus is present guides clinical decision-making, helps protect vulnerable populations, and ensures early intervention. This test is widely used in hospitals and clinics due to its accuracy, speed, and ability to identify infections that might otherwise be missed with standard tests.

This test detects antibodies to Entamoeba histolytica, the parasite responsible for amoebiasis. Blood is collected, and results help healthcare providers diagnose current or past infection, guiding appropriate treatment to prevent intestinal or liver complications. Early detection enables timely therapy, reduces risk of chronic disease, malnutrition, or abscess formation, and improves patient outcomes. Understanding antibody status helps manage symptoms and prevent spread of infection.

This test measures the level of antistreptolysin O (ASO) antibodies in the blood, which are produced by the immune system in response to infection with Streptococcus bacteria, the cause of conditions such as strep throat or scarlet fever. Blood is collected via venipuncture, and results are interpreted alongside clinical symptoms and other laboratory findings. Elevated ASOT levels indicate a recent or past streptococcal infection, helping healthcare providers diagnose post-streptococcal complications such as rheumatic fever or glomerulonephritis. Early detection allows timely treatment and monitoring to prevent long-term complications affecting the heart, kidneys, or joints. Understanding ASOT levels empowers patients to take proactive steps in managing infections, adhere to treatment plans, and reduce the risk of recurrent illness or immune-related complications. This test is particularly useful for patients with a history of repeated strep infections or unexplained inflammatory conditions.

This test detects antibodies to arboviruses, a group of viruses transmitted by mosquitoes and other insects, which can cause fever, joint pain, or neurological complications. Blood is collected, and results help diagnose current or past infection, guide treatment, and inform preventive measures such as mosquito avoidance or vaccination. Early detection reduces complications, guides public health measures, and supports patient awareness of potential viral exposure and long-term health monitoring.

This test detects antibodies against Ascaris lumbricoides, a parasitic roundworm that can cause intestinal infections. Blood is collected, and results help healthcare providers diagnose current or past infections. Early detection allows for timely treatment with antiparasitic medications, preventing complications such as malnutrition, anemia, and intestinal obstruction. Patients benefit from understanding their exposure risk and implementing preventive hygiene measures.

This test measures beta-D glucan, a component of fungal cell walls, to detect invasive fungal infections. Blood is collected and analysed to identify infections early, particularly in immunocompromised patients. Early detection allows timely antifungal therapy, preventing severe complications and supporting recovery. Understanding beta-D glucan levels helps healthcare providers monitor treatment response and assess ongoing infection risk. Patients gain insight into immune status and infection management.

This test measures Schistosoma (Bilharzia) antigen in urine to detect parasitic infection. Urine is collected, and results help healthcare providers diagnose current infection and guide antiparasitic therapy. Early detection prevents complications such as urinary tract damage, liver fibrosis, or chronic infection. Patients gain insight into exposure risk, enabling timely treatment and preventive measures to maintain long-term health.

This test screens for antibodies to Schistosome parasites, indicating past or current infection. Blood is collected and analysed to help healthcare providers diagnose infection, monitor response to treatment, and prevent complications. Early detection reduces risk of organ damage, anemia, and chronic disease. Patients benefit from timely intervention and guidance on preventive strategies.

This test detects BK polyoma virus using polymerase chain reaction (PCR), a highly sensitive method for identifying viral DNA. The virus can remain dormant but may reactivate in immunocompromised individuals, potentially affecting the kidneys and urinary tract. Blood or urine samples are collected, and PCR amplifies viral genetic material to confirm infection. Early detection allows healthcare providers to monitor viral activity, adjust immunosuppressive therapy if necessary, and prevent complications such as kidney dysfunction. Understanding BK virus status empowers patients to manage health proactively, especially after organ transplants or during conditions affecting the immune system. Accurate detection supports timely intervention and long-term monitoring.

This test detects antibodies against Candida, a yeast that can cause infections in the mouth, skin, or bloodstream. Blood is collected and analysed to identify exposure or infection. Early detection allows healthcare providers to prescribe antifungal therapy, monitor response, and prevent complications. Patients benefit by managing infections proactively, protecting overall health, and reducing the risk of systemic spread.

This test involves culturing Candida from clinical samples, such as blood, urine, or swabs, to identify infection. Laboratory growth helps determine the type and susceptibility of the yeast. Early detection and identification allow healthcare providers to implement targeted antifungal therapy, prevent complications, and monitor patient recovery. Patients benefit from accurate diagnosis, timely treatment, and reduced risk of recurrent infection.

This test cultures Candida from groin or skin samples to detect local fungal infection. Samples are collected and analysed for yeast growth and susceptibility to treatment. Early detection allows healthcare providers to prescribe appropriate antifungal therapy, monitor infection resolution, and prevent spread. Patients benefit from accurate diagnosis, effective treatment, and guidance to maintain skin health and prevent recurrence.

This test detects antibodies against Trypanosoma cruzi, the parasite causing Chagas disease. Blood is drawn and analysed to confirm exposure or infection. Early detection allows healthcare providers to initiate antiparasitic treatment, prevent cardiac or gastrointestinal complications, and monitor long-term outcomes. Patients benefit from timely diagnosis, disease management, and guidance on prevention in endemic regions.

This test detects antibodies against chikungunya virus, which is transmitted by mosquitoes and can cause fever, joint pain, and fatigue. Blood is drawn and analysed to confirm recent or past infection. Early detection helps healthcare providers guide treatment, manage symptoms, and implement preventive measures. Patients benefit from understanding exposure risk, reducing complications, and supporting recovery and long-term health.

Get peace of mind with private infectious disease screening and early detection tests.

Book An Appointment

This test detects Chlamydia and Gonorrhoea infections using PCR from a swab sample. The test is highly sensitive and can identify infections in the genital tract, throat, or other sites. Early detection allows healthcare providers to initiate antibiotic treatment, prevent complications, and reduce transmission. Patients benefit from accurate diagnosis, timely therapy, and guidance on sexual health and safe practices.

This test detects Chlamydia and Gonorrhoea using PCR from a ThinPrep sample, often collected during routine gynecological exams. Early detection helps healthcare providers prevent complications such as pelvic inflammatory disease or infertility. Timely treatment and monitoring reduce risk of spread, and patients benefit from safe sexual health management and preventive care.

This test detects Chlamydia and Gonorrhoea via PCR from a throat swab, identifying infections that may be asymptomatic. Early detection allows healthcare providers to provide targeted antibiotic therapy, prevent transmission, and reduce complications. Patients gain peace of mind and guidance for maintaining sexual health and safety.

This test detects Chlamydia and Gonorrhoea using PCR from urine samples, a non-invasive method suitable for both men and women. Positive results allow healthcare providers to initiate effective treatment, prevent complications, and reduce the risk of further spread. Patients benefit from convenience, early diagnosis, and comprehensive sexual health management.

This test cultures samples from any site (blood, swab, urine, or tissue) to identify bacterial, fungal, or other infectious organisms. Samples are collected and analysed in the laboratory for pathogen growth and susceptibility. Early detection allows healthcare providers to prescribe targeted antimicrobial therapy, prevent complications, and monitor recovery. Patients benefit from accurate diagnosis, timely treatment, and improved infection control and overall health outcomes.

This test detects antibodies to dengue virus, which is transmitted by mosquitoes and can cause fever, rash, joint pain, and bleeding complications. Blood is collected and analysed to identify recent or past infection. Early detection allows healthcare providers to monitor symptoms, manage complications, and provide advice on preventive measures to reduce future exposure. Patients benefit from timely diagnosis, guided treatment, and education on avoiding mosquito-borne diseases, improving overall health and safety.

This test detects diphtheria antibodies, assessing immunity to the bacterial infection that can cause respiratory illness, heart, and nerve complications. Blood is drawn and analysed to confirm protection levels or determine the need for booster vaccination. Understanding antibody status helps healthcare providers prevent infection, guide vaccination schedules, and protect public health. Patients benefit from immunity awareness, informed healthcare decisions, and reduced risk of severe illness.

This test detects antibodies against Echinococcus (hydatid disease), a parasitic infection that can affect the liver, lungs, or other organs. Blood is drawn and analysed to confirm infection. Early detection allows healthcare providers to initiate medical or surgical treatment, prevent complications such as cyst rupture, and monitor recovery. Patients benefit from timely diagnosis, proactive disease management, and preventive guidance for reducing exposure, especially in endemic regions.

This test measures Epstein-Barr Virus (EBV) antibodies IgG and IgM to detect past or recent infection. Blood is drawn and analysed to identify immune response to EBV, which can cause mononucleosis, fatigue, or complications in immunocompromised individuals. Results help healthcare providers guide diagnosis, monitor recovery, and provide preventive advice. Patients benefit by understanding exposure status, managing symptoms, and reducing the risk of future complications.

This test detects EBV using PCR, a sensitive method to identify viral DNA, confirming active infection. Blood is drawn and analysed, allowing healthcare providers to monitor viral activity, guide treatment, and assess recovery. Early detection supports timely management, prevents complications, and informs monitoring in immunocompromised patients. Patients benefit by identifying infection status, receiving proper care, and protecting long-term health.

Measures antibodies against Hib bacteria, which can cause serious infections like meningitis or pneumonia. Indicates immunity from vaccination or prior exposure. Healthcare providers use this test to ensure protection, particularly in children or immunocompromised adults. Blood is collected via venipuncture, and results guide preventive care or booster vaccinations.
This combined test screens for hepatitis A, B, and C infections using a blood sample. It detects antibodies and antigens to identify current or past infections and assess immunity. Results help healthcare providers guide vaccination, antiviral therapy, and preventive measures. Patients benefit from early detection, effective disease management, and reduced risk of liver damage, cirrhosis, or long-term complications. Comprehensive testing provides insight into liver health, supports public health measures, and enables informed decisions regarding exposure, lifestyle adjustments, and treatment options.Measures antibodies against Hib bacteria, which can cause serious infections like meningitis or pneumonia. Indicates immunity from vaccination or prior exposure. Healthcare providers use this test to ensure protection, particularly in children or immunocompromised adults. Blood is collected via venipuncture, and results guide preventive care or booster vaccinations.
This test detects IgM antibodies to hepatitis A virus, indicating recent or acute infection. Blood is collected and analysed to confirm infection status. Early detection allows healthcare providers to monitor liver function, provide supportive care, and prevent transmission. Patients benefit by understanding infection status, implementing hygiene precautions, and receiving guidance for safe recovery. Timely identification reduces risk of liver complications, supports symptom management, and ensures appropriate follow-up for long-term liver health.
This test assesses immunity to hepatitis A virus by measuring IgG and IgM antibodies. Blood is collected to determine if the patient is protected from infection due to previous exposure or vaccination. Healthcare providers use results to guide vaccination schedules or confirm immunity. Patients benefit by understanding protection status, preventing infection, and reducing risk of liver disease. This test supports informed decisions about travel, lifestyle precautions, and long-term liver wellness.

This comprehensive profile evaluates antibodies and markers for hepatitis A virus, assessing current infection or immunity. Blood is collected and analysed to determine if infection is acute, past, or if immunity is present. Early detection allows healthcare providers to monitor liver function, guide vaccination, and implement preventive measures. Patients benefit by understanding risk, protecting liver health, and taking informed steps to prevent transmission and complications, ensuring long-term well-being.

This test measures total antibodies against the core antigen of hepatitis B virus, indicating previous or ongoing infection. Blood is collected and analysed to determine immune response and infection status. Healthcare providers use results to guide further testing, vaccination, or treatment. Patients benefit by understanding their hepatitis B status, reducing liver disease risk, and taking preventive or therapeutic measures. Early identification helps prevent complications and supports long-term liver health.

This test measures total antibodies against the core antigen of hepatitis B virus, indicating previous or ongoing infection. Blood is collected and analysed to determine immune response and infection status. Healthcare providers use results to guide further testing, vaccination, or treatment. Patients benefit by understanding their hepatitis B status, reducing liver disease risk, and taking preventive or therapeutic measures. Early identification helps prevent complications and supports long-term liver health.

This test measures the level of protective antibodies against hepatitis B, indicating immunity from vaccination or past infection. Blood is collected and analysed to determine if booster vaccination is necessary. Healthcare providers use results to guide preventive care and assess risk of infection. Patients benefit by understanding their immune status, preventing hepatitis B, and maintaining long-term liver health through informed vaccination decisions.

This profile evaluates multiple markers for hepatitis B virus, including surface antigen, core antibodies, and e antigen/antibodies. Blood is collected and analysed to determine current infection, immunity, or viral replication. Results guide healthcare providers in treatment planning, vaccination, and monitoring disease progression. Patients benefit from early detection, personalised care, and prevention of liver-related complications, ensuring long-term wellness and informed management of hepatitis B.

This test detects hepatitis B surface antigen, indicating current infection. Blood is collected and analysed to confirm infection status, monitor viral activity, and guide treatment. Early detection allows healthcare providers to prevent liver damage, reduce transmission risk, and monitor therapy effectiveness. Patients benefit by understanding infection status, implementing preventive measures, and protecting long-term liver and overall health.

This test detects antibodies to hepatitis C virus, indicating current or past infection. Blood is collected and analysed to assess exposure and guide further testing for viral RNA if needed. Healthcare providers use results to determine the need for antiviral therapy, monitor disease progression, and prevent liver complications. Patients benefit by understanding their HCV status, receiving timely treatment, and reducing long-term risks of cirrhosis, liver failure, or transmission.

This test detects antibodies to hepatitis C virus, indicating current or past infection. Blood is collected and analysed to assess exposure and guide further testing for viral RNA if needed. Healthcare providers use results to determine the need for antiviral therapy, monitor disease progression, and prevent liver complicatiThis test measures hepatitis C virus RNA in the blood, indicating viral activity and infection severity. Blood is collected and analysed to guide treatment decisions, monitor therapy response, and assess prognosis. Early detection and monitoring allow healthcare providers to adjust antiviral therapy and prevent liver damage. Patients benefit by understanding viral levels, optimising treatment effectiveness, and protecting long-term liver health.ons. Patients benefit by understanding their HCV status, receiving timely treatment, and reducing long-term risks of cirrhosis, liver failure, or transmission.

This test detects antibodies to hepatitis D virus, which can co-infect or super-infect individuals with hepatitis B. Blood is collected and analysed to identify exposure or infection. Early detection allows healthcare providers to guide monitoring, treatment, and preventive measures. Patients benefit by understanding risk, reducing liver complications, and implementing strategies to protect long-term liver function and overall wellness.

This test measures antibodies to hepatitis E virus to detect past (IgG) or recent (IgM) infection. Blood is collected and analysed to assess immunity, active infection, and exposure risk. Healthcare providers use results to guide monitoring, treatment, and preventive measures, especially in vulnerable populations. Patients benefit by understanding infection status, protecting liver health, and taking steps to prevent future HEV-related complications.

The Hepatitis B Core IgM test detects recent or acute Hepatitis B infection by measuring IgM antibodies produced by the immune system. It is especially useful for patients presenting with symptoms like jaundice, fatigue, dark urine, or abdominal discomfort. Detecting IgM antibodies helps healthcare providers differentiate new infections from past exposure or immunity and guides decisions about monitoring and treatment. Blood is drawn via venipuncture, and results are interpreted alongside other hepatitis markers and liver function tests. Understanding your results allows for timely intervention, prevents complications such as liver inflammation, and informs strategies to reduce transmission risk to others.

This test measures IgG antibodies against Herpes Simplex Virus types 1 and 2, which indicate past infection. It helps determine immunity and potential risk for transmission. Patients may be asymptomatic, so testing can identify previous exposure even without symptoms. A blood sample is taken, and results help healthcare providers offer counseling, preventive strategies, and treatment if necessary. Understanding your antibody status can also guide decisions for pregnancy planning or managing recurrent symptoms, supporting both personal and sexual health.

This PCR test detects active Herpes Simplex Virus DNA from a swab, confirming current infection. It is highly sensitive and can differentiate between HSV-1 and HSV-2, helping diagnose outbreaks or unexplained lesions. The test is particularly useful in symptomatic individuals or those at risk of transmission. Accurate results allow healthcare providers to prescribe antiviral treatment promptly and provide guidance on preventing spread. PCR testing is essential for early intervention, managing symptoms, and reducing complications associated with HSV infections.
Detects active Herpes Simplex Virus DNA in urine, identifying infection when lesions are not easily accessible. Useful for urinary tract involvement or monitoring viral shedding in asymptomatic patients. Accurate results inform antiviral therapy and infection prevention measures. Blood or urine may be taken depending on symptoms, and results are interpreted alongside clinical presentation.
Measures IgM antibodies to Herpes Simplex Virus types 1 and 2, indicating recent or active infection. Helps differentiate recent outbreaks from past exposure. Patients with new lesions, fever, or discomfort benefit from this test to guide timely treatment and reduce transmission. Blood is drawn for analysis, and results are interpreted alongside clinical history and PCR tests. Understanding IgM results helps patients and healthcare providers make informed decisions about antiviral therapy and precautions.
Measures HIV-1 virus quantity in the blood, monitoring infection severity and treatment effectiveness. Used in newly diagnosed or treated HIV patients to guide therapy adjustments. Accurate viral load assessment helps track disease progression and the risk of transmission. Blood is collected, and results are interpreted alongside CD4 counts and antibody tests. Understanding viral load helps patients and healthcare providers optimise antiretroviral therapy, monitor adherence, and maintain long-term immune health.
This PCR/NAAT panel screens for early HIV, Hepatitis B, and Hepatitis C infection before antibodies are detectable. Ideal for patients with recent exposure or high-risk behaviors. Early detection allows prompt intervention, prevents disease progression, and reduces transmission risk. Blood is drawn, and results are interpreted by specialists. Understanding early infection status empowers patients to make informed healthcare decisions, start treatment if necessary, and adopt preventive measures.
Detects HIV antibodies (I & II) and p24 antigen, allowing early diagnosis of infection. Useful for screening after exposure or as part of routine sexual health checks. Blood is collected via venipuncture, and results are interpreted alongside viral load if positive. Early identification helps guide treatment initiation, reduce viral transmission, and improve long-term health outcomes.
Detects high-risk human papillomavirus (HPV) RNA, associated with cervical and other cancers. Helps identify active infection and guide follow-up screening or preventive care. Samples are usually collected from cervical swabs, and results are interpreted alongside cytology. Early detection of high-risk HPV allows timely intervention, reducing the risk of cancer progression.
Detects antibodies against H. pylori bacteria, a common cause of stomach ulcers and gastritis. A positive result suggests past or current infection, and helps guide treatment to prevent complications such as ulcers or stomach cancer. Blood is collected for testing, and results are interpreted alongside symptoms and other diagnostic tests. Understanding antibody status helps patients and healthcare providers manage infection and prevent gastrointestinal complications.
Detects active H. pylori infection via stool antigen. Helps confirm infection causing gastritis, ulcers, or abdominal discomfort. Useful for diagnosis and post-treatment monitoring. Stool samples are collected at home or clinic, and results guide treatment decisions. Timely identification allows appropriate eradication therapy to prevent complications and improve digestive health.
Detects antibodies to HTLV types 1 and 2, viruses that can cause blood and neurological disorders. Screening is important in at-risk populations or before transfusions. Blood is drawn and analysed, and results guide follow-up testing or counseling. Understanding HTLV status helps prevent transmission and monitor long-term health.
Measures IgG antibodies to HHV-8, associated with Kaposi’s sarcoma or other disorders in immunocompromised patients. Helps identify past infection and assess risk. Blood is drawn, and results are interpreted alongside clinical evaluation. Knowing your HHV-8 status guides monitoring and preventive strategies.
This test detects antibodies to Legionella bacteria, which cause Legionnaires’ disease, a type of pneumonia. Blood is collected and analysed to confirm past or recent infection. Early detection allows healthcare providers to prescribe appropriate antibiotics, monitor recovery, and prevent complications. Patients benefit by receiving timely diagnosis, effective treatment, and guidance to avoid future exposure.
This test detects Legionella antigens in urine, confirming active infection with Legionnaires’ disease. Urine is collected and analysed to identify bacterial proteins. Early detection allows healthcare providers to initiate prompt antibiotic therapy, monitor progress, and prevent severe complications such as respiratory failure. Patients benefit by receiving timely care, reducing disease severity, and ensuring long-term lung health.
This test detects antibodies to Leishmania, a parasite transmitted by sandflies. Blood is collected and analysed to confirm exposure or infection. Early detection allows healthcare providers to initiate treatment, prevent complications, and monitor recovery. Patients benefit by identifying infection risk, receiving timely therapy, and maintaining overall health, particularly in endemic areas.
This test detects IgM antibodies to Leptospira bacteria, which cause leptospirosis, a bacterial infection often acquired through contact with contaminated water or animals. Symptoms can include fever, muscle pain, headache, or jaundice. Early detection allows timely treatment with antibiotics, preventing complications such as kidney or liver damage. Blood is drawn, and results are interpreted alongside clinical symptoms and exposure history. Understanding your leptospirosis status helps healthcare providers manage infection effectively and guide preventive measures, particularly for at-risk individuals such as travelers, farmers, or outdoor workers.
Measures antibodies against Borrelia bacteria, which cause Lyme disease transmitted by tick bites. IgM indicates recent infection, IgG indicates past exposure. Helps confirm diagnosis in patients with fever, rash, or joint pain. Blood is drawn, and results guide treatment and follow-up monitoring. Early detection allows prompt antibiotic therapy and reduces risk of long-term complications such as neurological or joint involvement.
This test detects antibodies against Plasmodium falciparum, the parasite responsible for the most severe form of malaria. Blood is collected to determine whether the patient has been exposed to the parasite, indicating either past infection or immune response. Detecting these antibodies helps healthcare providers confirm previous exposure, assess immunity, and evaluate potential risk for future infection. Early identification allows for preventive counseling, monitoring for complications, and timely intervention if symptoms develop. Patients benefit by understanding their exposure history, reducing anxiety about infection, and supporting informed decisions regarding travel or prophylactic measures. Antibody testing complements diagnostic strategies, guiding healthcare providers in assessing overall malaria risk, planning vaccination or preventive strategies, and optimising long-term health in endemic or post-travel situations.
This test identifies active malaria parasites in the bloodstream using blood samples. The presence, type, and quantity of parasites are determined, which allows healthcare providers to diagnose infection accurately and provide immediate, targeted treatment. Detecting parasites early helps prevent severe complications such as anemia, cerebral malaria, organ dysfunction, and other life-threatening outcomes. Patients benefit by receiving timely therapy, minimising disease severity, and reducing recovery time. This test is especially important for travelers returning from malaria-endemic regions or patients presenting with fever, chills, or fatigue. By confirming parasitic infection, healthcare providers can implement evidence-based interventions, monitor patient progress, and improve long-term health outcomes, ensuring safety and proactive care for at-risk individuals.
This test measures immunity to measles by detecting IgG antibodies in the blood, reflecting either past infection or successful vaccination. Blood is collected and analysed to confirm protective immunity. Results help healthcare providers determine the need for booster vaccinations and prevent potential outbreaks. Patients benefit by understanding their immunity status, ensuring protection against measles, and making informed decisions regarding travel, exposure, or preventive healthcare. Timely assessment reduces the risk of infection, supports public health measures, and allows individuals to maintain long-term wellness and immunity to serious viral diseases
This test measures antibodies to meningococcal bacteria, evaluating immune protection against meningococcal disease. Blood is drawn and analysed to confirm vaccination efficacy or prior exposure. Results help healthcare providers recommend booster vaccinations, preventive strategies, and public health guidance. Patients benefit by understanding their immune status, preventing infection, and reducing risk of life-threatening complications such as meningitis or septicemia. This testing supports proactive health decisions, ensuring long-term protection and overall wellness against serious bacterial infections.
This rapid PCR test detects MRSA colonization in the groin. Swabs are collected and analysed to identify methicillin-resistant Staphylococcus aureus. Early identification allows healthcare providers to implement infection control measures, guide treatment, and prevent serious infections. Patients benefit by reducing risk of severe skin, soft tissue, or systemic infections, maintaining overall health, and protecting household or hospital contacts. Timely testing supports proactive infection management and long-term wellness.
This rapid PCR test detects MRSA colonization in the nasal passages. Swabs are collected and analysed to identify methicillin-resistant Staphylococcus aureus. Early detection allows healthcare providers to implement preventive measures, reduce transmission risk, and guide timely treatment. Patients benefit by maintaining health, preventing infection, and supporting long-term wellness.
This test measures IgG antibodies against mumps virus, confirming immunity from past infection or vaccination. Blood is collected and analysed to ensure protection and determine the need for booster vaccinations. Results guide healthcare providers in preventive care planning. Patients benefit by confirming immunity, reducing the risk of infection, and protecting long-term health. Timely testing supports informed health decisions and proactive preventive measures.
This test measures IgM antibodies against mumps virus to detect current or recent infection. Blood is drawn and analysed to confirm active infection. Early detection allows healthcare providers to manage symptoms, prevent transmission, and monitor recovery. Patients benefit by understanding infection status, implementing precautions, and reducing the risk of complications such as orchitis or meningitis. Prompt diagnosis supports timely care and overall wellness.
This test analyses nail clippings to assess exposure to heavy metals, toxins, and essential trace elements over time. Nail tissue can reflect long-term environmental and occupational exposures, including lead, mercury, and arsenic. Collected clippings are analysed in a laboratory to detect accumulation of these substances, which may affect organ function, neurological health, or metabolic balance. Results allow healthcare providers to identify chronic exposures, recommend dietary or lifestyle interventions, and monitor patient progress. Patients benefit by understanding potential toxin burdens, implementing preventive measures, and supporting overall wellness. Nail analysis provides a non-invasive, longitudinal view of exposure that complements other clinical assessments, helping patients maintain optimal health and reduce long-term risk of organ or neurological damage.
This test measures parvovirus IgG and IgM antibodies to detect past or recent infection. Blood is collected and analysed to determine immunity or active infection. Early identification helps healthcare providers monitor symptoms, provide treatment guidance, and implement preventive measures. Patients benefit by understanding infection status, ensuring immunity, reducing the risk of complications during pregnancy, and supporting overall health. Timely assessment enables informed healthcare decisions and proactive interventions.
This test detects heterophile antibodies associated with mononucleosis (Monospot). Blood is collected and analysed to confirm infection with Epstein-Barr virus. Early detection allows healthcare providers to manage symptoms, prevent complications, and provide guidance for recovery. Patients benefit by understanding infection status, receiving supportive care, and minimising the risk of transmission. Timely diagnosis supports informed care, symptom management, and overall wellness.
This test screens for atypical pneumonia pathogens using blood or respiratory samples. Analysis identifies bacterial or viral infections causing pneumonia symptoms. Early identification allows healthcare providers to implement targeted treatment, monitor recovery, and prevent complications. Patients benefit by receiving timely therapy, reducing illness severity, and maintaining respiratory and overall health. Screening improves early diagnosis, supports appropriate care, and promotes long-term wellness.
This test detects antibodies to Q fever (Coxiella burnetii), a bacterial infection that can cause flu-like illness, hepatitis, or endocarditis. Blood is collected and analysed to confirm exposure or active infection. Early detection allows healthcare providers to implement antibiotic therapy, monitor recovery, and prevent complications. Patients benefit by understanding infection status, managing illness effectively, and protecting long-term health. Timely testing supports informed healthcare decisions and preventive strategies.
This test measures rabies antibodies to assess immunity following vaccination or exposure. Blood is collected and analysed to confirm protective antibody levels. Results help healthcare providers determine the need for booster vaccinations and monitor immune response. Patients benefit by understanding rabies protection, preventing infection, and ensuring long-term health. Timely assessment supports preventive care and informed decision-making.
This test detects antibodies against Rickettsial species, a group of bacteria that can cause diseases such as spotted fever and typhus. Blood is collected and analysed to determine exposure or active infection. Early detection allows healthcare providers to prescribe targeted antibiotic therapy, monitor recovery, and prevent complications such as organ damage or severe systemic illness. Patients benefit by understanding infection risk, receiving timely care, and reducing the severity of illness. Regular testing is especially important for individuals with travel to endemic areas or exposure to vectors like ticks and fleas. Timely detection and monitoring ensure long-term wellness and effective management of potential Rickettsial infections.
This test detects rotavirus in stool samples using PCR technology to identify viral genetic material. Stool is collected and analysed to confirm infection, which is a common cause of severe gastroenteritis in children and adults. Early detection allows healthcare providers to implement hydration therapy, symptom management, and infection control measures. Patients benefit by understanding the cause of gastrointestinal symptoms, preventing dehydration, reducing transmission risk, and supporting recovery. Accurate identification of rotavirus infection helps guide treatment decisions, prevent complications, and maintain overall gastrointestinal and general health.
This test measures rubella IgG antibodies in blood to determine immunity from past infection or vaccination. Blood is collected and analysed to confirm protective antibody levels. Results help healthcare providers determine the need for booster vaccinations and provide guidance on reproductive health, particularly for women of childbearing age. Patients benefit by confirming immunity, reducing the risk of infection during pregnancy, and supporting long-term health. Timely assessment ensures effective preventive care, protects fetal health, and contributes to overall wellness. Monitoring immunity helps prevent outbreaks and provides reassurance regarding personal and public health protection.
This test measures rubella IgM antibodies to detect recent or current infection. Blood is collected and analysed to confirm active infection, which can be particularly important during pregnancy. Early detection allows healthcare providers to implement monitoring, counseling, and preventive measures to protect maternal and fetal health. Patients benefit by understanding infection status, receiving timely guidance, and reducing the risk of complications. Accurate and prompt detection supports informed decisions, preventive strategies, and overall wellness.
This stool test detects ova, cysts, and parasites to identify intestinal infections. Stool is collected and analysed to detect pathogens such as Giardia, Entamoeba, or helminths. Early detection allows healthcare providers to prescribe targeted treatment, prevent complications, and reduce transmission. Patients benefit by identifying infections promptly, receiving appropriate therapy, and maintaining digestive and overall health. Timely diagnosis supports informed care and long-term wellness.
This test detects Strongyloides antibodies, a parasitic infection that can persist chronically. Blood is collected and analysed to determine exposure or infection. Early detection allows healthcare providers to initiate appropriate treatment, prevent complications such as hyperinfection, and monitor recovery. Patients benefit by understanding infection risk, receiving timely therapy, and protecting long-term health. Timely assessment supports informed care and proactive management of parasitic infections.
This test analyses cervical swabs to detect infections, cellular abnormalities, or HPV presence. Samples are collected and analysed to identify bacterial, viral, or precancerous changes. Early detection allows healthcare providers to guide treatment, monitor progression, and prevent complications such as cervical cancer. Patients benefit by understanding cervical health, implementing preventive strategies, and supporting long-term reproductive wellness. Timely testing enables early intervention and overall wellness.
This test analyses eye swabs to detect bacterial or viral infections affecting ocular health. Swabs are collected and analysed to identify pathogens, guide treatment, and prevent complications such as keratitis or conjunctivitis. Patients benefit by understanding eye health status, receiving timely therapy, and maintaining vision and overall wellness. Early detection supports proactive care and informed management.
This test analyses swabs from any site of the body to detect bacterial, fungal, or viral infections. Samples are collected and cultured in a laboratory to identify pathogens accurately. Early detection allows healthcare providers to prescribe targeted treatment, monitor recovery, and prevent complications. Patients benefit by understanding infection status, receiving timely therapy, and maintaining long-term health. Testing supports proper diagnosis, reduces the risk of spreading infections, and promotes overall wellness. Accurate culture results also guide future preventive strategies, ensuring optimal care and reducing potential complications.
This test analyses nasal swabs to detect bacterial, viral, or fungal infections. Samples are collected and analysed to confirm infection, guide treatment, and monitor patient recovery. Early detection allows healthcare providers to recommend targeted interventions and preventive measures. Patients benefit by understanding nasal and respiratory health, managing symptoms proactively, and preventing complications. Timely testing ensures appropriate therapy, reduces transmission risk, and supports overall wellness. Accurate nasal swab analysis helps maintain respiratory and general health.
This test analyses oral swabs to detect bacterial, viral, or fungal infections affecting the mouth or throat. Samples are collected and cultured to identify pathogens, guide treatment, and monitor recovery. Early detection allows healthcare providers to implement targeted interventions, prevent complications, and reduce transmission. Patients benefit by understanding oral health status, receiving appropriate care, and supporting long-term wellness. Timely testing promotes informed health decisions, reduces symptom severity, and maintains oral and systemic health.
This test analyses penile swabs to detect sexually transmitted infections (STIs) such as chlamydia or gonorrhea. Swabs are collected and analysed to identify pathogens accurately. Early detection allows healthcare providers to implement targeted therapy, prevent complications, and reduce transmission to partners. Patients benefit by understanding infection status, receiving timely treatment, and maintaining sexual and reproductive health. Accurate testing supports informed decisions, reduces long-term health risks, and promotes overall wellness.
This test analyses oral swabs to detect bacterial, viral, or fungal infections affecting the mouth or throat. Samples are collected and cultured to identify pathogens, guide treatment, and monitor recovery. Early detection allows healthcare providers to implement targeted interventions, prevent complications, and reduce transmission. Patients benefit by understanding oral health status, receiving appropriate care, and supporting long-term wellness. Timely testing promotes informed health decisions, reduces symptom severity, and maintains oral and systemic health.
This test analyses skin swabs to detect bacterial, fungal, or viral infections affecting the skin. Swabs are collected and cultured to identify pathogens accurately. Early detection allows healthcare providers to guide treatment, monitor healing, and prevent complications. Patients benefit by understanding skin health, receiving timely therapy, reducing spread, and supporting long-term wellness. Accurate swab analysis informs preventive care, supports rapid recovery, and maintains overall health.
This test analyses throat swabs to detect bacterial, viral, or fungal infections such as strep throat. Samples are collected and cultured to identify pathogens accurately. Early detection allows healthcare providers to recommend targeted therapy, monitor recovery, and prevent complications. Patients benefit by understanding throat health, managing symptoms proactively, and supporting long-term wellness. Timely testing reduces transmission risk and ensures appropriate care, promoting optimal oral and systemic health.
This test analyses vulval swabs to detect infections including bacterial, viral, or fungal pathogens. Samples are collected and cultured to identify causative organisms. Early detection allows healthcare providers to implement treatment, prevent complications, and reduce transmission. Patients benefit by understanding vulval health, receiving timely care, and maintaining reproductive and overall wellness. Accurate testing supports informed decisions, symptom management, and long-term health outcomes.
This test analyses wound swabs to detect bacterial, viral, or fungal infections in wounds, surgical sites, or injuries. Samples are collected and cultured to identify pathogens accurately. Early detection allows healthcare providers to prescribe targeted therapy, prevent infection spread, and monitor healing. Patients benefit by understanding wound health, reducing risk of complications, and supporting long-term wellness. Timely testing ensures proper infection control, optimal recovery, and overall health maintenance.
This test measures antibodies for syphilis (IgG/IgM) to detect current or past infection. Blood is collected and analysed to guide treatment, monitor recovery, and prevent transmission. Early detection allows healthcare providers to prescribe antibiotics, prevent complications such as neurological or cardiovascular involvement, and ensure follow-up care. Patients benefit by understanding infection status, receiving timely therapy, reducing risk of long-term complications, and maintaining sexual and overall health. Accurate testing supports informed decisions and preventive measures.
This test measures immune response to tuberculosis using the Quantiferon-TB Gold assay. Blood is collected to detect latent or active TB infection by measuring interferon-gamma release. Early detection allows healthcare providers to initiate treatment, prevent active disease, and reduce transmission. Patients benefit by understanding TB exposure, receiving timely interventions, and protecting long-term respiratory and overall health. Accurate testing supports informed decisions, preventive care, and public health safety.
This test measures tetanus antibodies in blood to determine immunity following vaccination or exposure. Blood is collected and analysed to assess protective antibody levels. Results help healthcare providers recommend booster doses if needed, ensuring continued protection against tetanus. Patients benefit by understanding immunity status, preventing infection, and supporting long-term health. Timely assessment ensures preventive care, informed decision-making, and overall wellness.
This test detects toxoplasma antibodies (IgG and IgM) to determine past or recent infection. Blood is collected and analysed to assess immune status and guide pregnancy or immunocompromised care. Early detection allows healthcare providers to monitor infection, recommend interventions, and prevent complications such as congenital transmission. Patients benefit by understanding infection risk, receiving timely guidance, and supporting long-term health. Timely testing ensures proactive care, informed decisions, and overall wellness.
This test measures Treponema pallidum particle agglutination (TPPA) antibodies to detect syphilis infection. Blood is collected and analysed to confirm past or current infection. Early detection allows healthcare providers to implement antibiotic therapy, monitor disease progression, and prevent complications. Patients benefit by understanding infection status, receiving timely treatment, reducing long-term risks, and maintaining sexual and overall health. Accurate testing supports informed healthcare decisions and preventive strategies.
This test analyses urine microscopy and culture to detect urinary tract infections, kidney disorders, or abnormal cellular components. Urine is collected and examined to identify pathogens or abnormalities. Early detection allows healthcare providers to guide treatment, monitor recovery, and prevent complications. Patients benefit by understanding urinary health, receiving timely care, and supporting long-term wellness. Accurate testing supports informed decisions, infection prevention, and overall health maintenance.
This test analyses vaginal swabs to detect bacterial, viral, or fungal infections, including STIs. Samples are collected and cultured to identify pathogens accurately. Early detection allows healthcare providers to implement treatment, monitor recovery, and prevent complications. Patients benefit by understanding vaginal health, reducing infection risks, and supporting reproductive and overall wellness. Timely testing ensures informed decisions, preventive care, and long-term health maintenance.

This test measures VZV IgG antibodies to confirm immunity to chickenpox or shingles. Blood is collected and analysed to determine if protective levels are present. Results help healthcare providers recommend vaccination or booster doses if needed. Patients benefit by understanding immunity status, preventing infection, and supporting long-term health. Timely testing ensures proactive preventive care and informed healthcare decisions.

This test measures VZV IgG antibodies to confirm immunity to chickenpox or shingles. Blood is collected and analysed to determine if protective levels are present. Results help healthcare providers recommend vaccination or booster doses if needed. Patients benefit by understanding immunity status, preventing infection, and supporting long-term health. Timely testing ensures proactive preventive care and informed healthcare decisions.

This test measures antibodies to respiratory viruses to screen for viral respiratory infections. Blood or swabs are collected and analysed to detect pathogens such as influenza, RSV, or adenovirus. Early detection allows healthcare providers to implement appropriate therapy, monitor recovery, and prevent complications. Patients benefit by understanding infection status, receiving timely care, reducing severity, and supporting overall health. Accurate testing informs preventive strategies and long-term wellness.

This test measures antibodies against pertussis (whooping cough) to evaluate immunity or past infection. Blood is collected and analysed to determine whether protective antibody levels are present. Results help healthcare providers assess immunity, recommend booster vaccination if needed, and reduce risk of infection. Patients benefit by understanding protection status, preventing disease, and supporting long-term respiratory health. Timely testing ensures informed preventive care and wellness.

This test measures antibodies against yellow fever virus to confirm immunity or previous exposure. Blood is collected and analysed to determine protective antibody levels. Results help healthcare providers assess vaccination efficacy, guide booster recommendations, and prevent infection. Patients benefit by understanding immunity status, reducing infection risk, and supporting long-term health, particularly when traveling to endemic areas. Timely assessment ensures effective preventive care and wellness.

This test measures antibodies against Yersinia bacteria, which can cause gastrointestinal infections. Blood is collected and analysed to detect past or current infection. Early identification allows healthcare providers to guide treatment, monitor recovery, and prevent complications. Patients benefit by understanding exposure status, implementing preventive measures, and maintaining long-term gastrointestinal and overall health. Timely testing supports informed healthcare decisions and proactive management.

This test detects Zika virus IgM and IgG antibodies to assess recent or past infection. Blood is collected and analysed to determine immunity or current exposure, particularly important for pregnant women. Early detection allows healthcare providers to implement preventive measures, monitor complications, and provide counseling. Patients benefit by understanding infection risk, taking timely action, and supporting long-term reproductive and general health. Accurate testing ensures proactive care and overall wellness.

Safeguard your health with accurate infection testing and confidential results from Bids Chemist.

Book An Appointment

This test detects adenovirus genetic material using polymerase chain reaction (PCR), a highly sensitive method to identify viral infections. Adenoviruses can cause respiratory infections, conjunctivitis, gastroenteritis, or systemic illness, particularly in children or immunocompromised individuals. Samples can be taken from blood, throat, or swabs from affected areas. PCR amplifies the virus’s genetic material, allowing precise detection even in early infection. Rapid identification helps healthcare providers implement timely treatment, manage symptoms, and prevent further transmission. Knowing whether adenovirus is present guides clinical decision-making, helps protect vulnerable populations, and ensures early intervention. This test is widely used in hospitals and clinics due to its accuracy, speed, and ability to identify infections that might otherwise be missed with standard tests.

This test detects antibodies to Entamoeba histolytica, the parasite responsible for amoebiasis. Blood is collected, and results help healthcare providers diagnose current or past infection, guiding appropriate treatment to prevent intestinal or liver complications. Early detection enables timely therapy, reduces risk of chronic disease, malnutrition, or abscess formation, and improves patient outcomes. Understanding antibody status helps manage symptoms and prevent spread of infection.

This test measures the level of antistreptolysin O (ASO) antibodies in the blood, which are produced by the immune system in response to infection with Streptococcus bacteria, the cause of conditions such as strep throat or scarlet fever. Blood is collected via venipuncture, and results are interpreted alongside clinical symptoms and other laboratory findings. Elevated ASOT levels indicate a recent or past streptococcal infection, helping healthcare providers diagnose post-streptococcal complications such as rheumatic fever or glomerulonephritis. Early detection allows timely treatment and monitoring to prevent long-term complications affecting the heart, kidneys, or joints. Understanding ASOT levels empowers patients to take proactive steps in managing infections, adhere to treatment plans, and reduce the risk of recurrent illness or immune-related complications. This test is particularly useful for patients with a history of repeated strep infections or unexplained inflammatory conditions.

This test detects antibodies to arboviruses, a group of viruses transmitted by mosquitoes and other insects, which can cause fever, joint pain, or neurological complications. Blood is collected, and results help diagnose current or past infection, guide treatment, and inform preventive measures such as mosquito avoidance or vaccination. Early detection reduces complications, guides public health measures, and supports patient awareness of potential viral exposure and long-term health monitoring.
 
This test detects antibodies against Ascaris lumbricoides, a parasitic roundworm that can cause intestinal infections. Blood is collected, and results help healthcare providers diagnose current or past infections. Early detection allows for timely treatment with antiparasitic medications, preventing complications such as malnutrition, anemia, and intestinal obstruction. Patients benefit from understanding their exposure risk and implementing preventive hygiene measures.
This test measures beta-D glucan, a component of fungal cell walls, to detect invasive fungal infections. Blood is collected and analysed to identify infections early, particularly in immunocompromised patients. Early detection allows timely antifungal therapy, preventing severe complications and supporting recovery. Understanding beta-D glucan levels helps healthcare providers monitor treatment response and assess ongoing infection risk. Patients gain insight into immune status and infection management.
This test measures Schistosoma (Bilharzia) antigen in urine to detect parasitic infection. Urine is collected, and results help healthcare providers diagnose current infection and guide antiparasitic therapy. Early detection prevents complications such as urinary tract damage, liver fibrosis, or chronic infection. Patients gain insight into exposure risk, enabling timely treatment and preventive measures to maintain long-term health.
This test screens for antibodies to Schistosome parasites, indicating past or current infection. Blood is collected and analysed to help healthcare providers diagnose infection, monitor response to treatment, and prevent complications. Early detection reduces risk of organ damage, anemia, and chronic disease. Patients benefit from timely intervention and guidance on preventive strategies.
This test detects BK polyoma virus using polymerase chain reaction (PCR), a highly sensitive method for identifying viral DNA. The virus can remain dormant but may reactivate in immunocompromised individuals, potentially affecting the kidneys and urinary tract. Blood or urine samples are collected, and PCR amplifies viral genetic material to confirm infection. Early detection allows healthcare providers to monitor viral activity, adjust immunosuppressive therapy if necessary, and prevent complications such as kidney dysfunction. Understanding BK virus status empowers patients to manage health proactively, especially after organ transplants or during conditions affecting the immune system. Accurate detection supports timely intervention and long-term monitoring.
This test detects antibodies against Candida, a yeast that can cause infections in the mouth, skin, or bloodstream. Blood is collected and analysed to identify exposure or infection. Early detection allows healthcare providers to prescribe antifungal therapy, monitor response, and prevent complications. Patients benefit by managing infections proactively, protecting overall health, and reducing the risk of systemic spread.
This test involves culturing Candida from clinical samples, such as blood, urine, or swabs, to identify infection. Laboratory growth helps determine the type and susceptibility of the yeast. Early detection and identification allow healthcare providers to implement targeted antifungal therapy, prevent complications, and monitor patient recovery. Patients benefit from accurate diagnosis, timely treatment, and reduced risk of recurrent infection.
This test cultures Candida from groin or skin samples to detect local fungal infection. Samples are collected and analysed for yeast growth and susceptibility to treatment. Early detection allows healthcare providers to prescribe appropriate antifungal therapy, monitor infection resolution, and prevent spread. Patients benefit from accurate diagnosis, effective treatment, and guidance to maintain skin health and prevent recurrence.
This test detects antibodies against Trypanosoma cruzi, the parasite causing Chagas disease. Blood is drawn and analysed to confirm exposure or infection. Early detection allows healthcare providers to initiate antiparasitic treatment, prevent cardiac or gastrointestinal complications, and monitor long-term outcomes. Patients benefit from timely diagnosis, disease management, and guidance on prevention in endemic regions.
This test detects antibodies against chikungunya virus, which is transmitted by mosquitoes and can cause fever, joint pain, and fatigue. Blood is drawn and analysed to confirm recent or past infection. Early detection helps healthcare providers guide treatment, manage symptoms, and implement preventive measures. Patients benefit from understanding exposure risk, reducing complications, and supporting recovery and long-term health.

Get peace of mind with private infectious disease screening and early detection tests.

Book An Appointment

This test detects Chlamydia and Gonorrhoea infections using PCR from a swab sample. The test is highly sensitive and can identify infections in the genital tract, throat, or other sites. Early detection allows healthcare providers to initiate antibiotic treatment, prevent complications, and reduce transmission. Patients benefit from accurate diagnosis, timely therapy, and guidance on sexual health and safe practices.

This test detects Chlamydia and Gonorrhoea using PCR from a ThinPrep sample, often collected during routine gynecological exams. Early detection helps healthcare providers prevent complications such as pelvic inflammatory disease or infertility. Timely treatment and monitoring reduce risk of spread, and patients benefit from safe sexual health management and preventive care.

This test detects Chlamydia and Gonorrhoea via PCR from a throat swab, identifying infections that may be asymptomatic. Early detection allows healthcare providers to provide targeted antibiotic therapy, prevent transmission, and reduce complications. Patients gain peace of mind and guidance for maintaining sexual health and safety.

This test detects Chlamydia and Gonorrhoea using PCR from urine samples, a non-invasive method suitable for both men and women. Positive results allow healthcare providers to initiate effective treatment, prevent complications, and reduce the risk of further spread. Patients benefit from convenience, early diagnosis, and comprehensive sexual health management.

This test cultures samples from any site (blood, swab, urine, or tissue) to identify bacterial, fungal, or other infectious organisms. Samples are collected and analysed in the laboratory for pathogen growth and susceptibility. Early detection allows healthcare providers to prescribe targeted antimicrobial therapy, prevent complications, and monitor recovery. Patients benefit from accurate diagnosis, timely treatment, and improved infection control and overall health outcomes.

This test detects antibodies to dengue virus, which is transmitted by mosquitoes and can cause fever, rash, joint pain, and bleeding complications. Blood is collected and analysed to identify recent or past infection. Early detection allows healthcare providers to monitor symptoms, manage complications, and provide advice on preventive measures to reduce future exposure. Patients benefit from timely diagnosis, guided treatment, and education on avoiding mosquito-borne diseases, improving overall health and safety.

This test detects diphtheria antibodies, assessing immunity to the bacterial infection that can cause respiratory illness, heart, and nerve complications. Blood is drawn and analysed to confirm protection levels or determine the need for booster vaccination. Understanding antibody status helps healthcare providers prevent infection, guide vaccination schedules, and protect public health. Patients benefit from immunity awareness, informed healthcare decisions, and reduced risk of severe illness.

This test detects antibodies against Echinococcus (hydatid disease), a parasitic infection that can affect the liver, lungs, or other organs. Blood is drawn and analysed to confirm infection. Early detection allows healthcare providers to initiate medical or surgical treatment, prevent complications such as cyst rupture, and monitor recovery. Patients benefit from timely diagnosis, proactive disease management, and preventive guidance for reducing exposure, especially in endemic regions.

This test measures Epstein-Barr Virus (EBV) antibodies IgG and IgM to detect past or recent infection. Blood is drawn and analysed to identify immune response to EBV, which can cause mononucleosis, fatigue, or complications in immunocompromised individuals. Results help healthcare providers guide diagnosis, monitor recovery, and provide preventive advice. Patients benefit by understanding exposure status, managing symptoms, and reducing the risk of future complications.

This test detects EBV using PCR, a sensitive method to identify viral DNA, confirming active infection. Blood is drawn and analysed, allowing healthcare providers to monitor viral activity, guide treatment, and assess recovery. Early detection supports timely management, prevents complications, and informs monitoring in immunocompromised patients. Patients benefit by identifying infection status, receiving proper care, and protecting long-term health.

Measures antibodies against Hib bacteria, which can cause serious infections like meningitis or pneumonia. Indicates immunity from vaccination or prior exposure. Healthcare providers use this test to ensure protection, particularly in children or immunocompromised adults. Blood is collected via venipuncture, and results guide preventive care or booster vaccinations.

This combined test screens for hepatitis A, B, and C infections using a blood sample. It detects antibodies and antigens to identify current or past infections and assess immunity. Results help healthcare providers guide vaccination, antiviral therapy, and preventive measures. Patients benefit from early detection, effective disease management, and reduced risk of liver damage, cirrhosis, or long-term complications. Comprehensive testing provides insight into liver health, supports public health measures, and enables informed decisions regarding exposure, lifestyle adjustments, and treatment options.Measures antibodies against Hib bacteria, which can cause serious infections like meningitis or pneumonia. Indicates immunity from vaccination or prior exposure. Healthcare providers use this test to ensure protection, particularly in children or immunocompromised adults. Blood is collected via venipuncture, and results guide preventive care or booster vaccinations.

This test detects IgM antibodies to hepatitis A virus, indicating recent or acute infection. Blood is collected and analysed to confirm infection status. Early detection allows healthcare providers to monitor liver function, provide supportive care, and prevent transmission. Patients benefit by understanding infection status, implementing hygiene precautions, and receiving guidance for safe recovery. Timely identification reduces risk of liver complications, supports symptom management, and ensures appropriate follow-up for long-term liver health.

This test assesses immunity to hepatitis A virus by measuring IgG and IgM antibodies. Blood is collected to determine if the patient is protected from infection due to previous exposure or vaccination. Healthcare providers use results to guide vaccination schedules or confirm immunity. Patients benefit by understanding protection status, preventing infection, and reducing risk of liver disease. This test supports informed decisions about travel, lifestyle precautions, and long-term liver wellness.

This comprehensive profile evaluates antibodies and markers for hepatitis A virus, assessing current infection or immunity. Blood is collected and analysed to determine if infection is acute, past, or if immunity is present. Early detection allows healthcare providers to monitor liver function, guide vaccination, and implement preventive measures. Patients benefit by understanding risk, protecting liver health, and taking informed steps to prevent transmission and complications, ensuring long-term well-being.

This test measures total antibodies against the core antigen of hepatitis B virus, indicating previous or ongoing infection. Blood is collected and analysed to determine immune response and infection status. Healthcare providers use results to guide further testing, vaccination, or treatment. Patients benefit by understanding their hepatitis B status, reducing liver disease risk, and taking preventive or therapeutic measures. Early identification helps prevent complications and supports long-term liver health.

This test measures total antibodies against the core antigen of hepatitis B virus, indicating previous or ongoing infection. Blood is collected and analysed to determine immune response and infection status. Healthcare providers use results to guide further testing, vaccination, or treatment. Patients benefit by understanding their hepatitis B status, reducing liver disease risk, and taking preventive or therapeutic measures. Early identification helps prevent complications and supports long-term liver health.

This test measures the level of protective antibodies against hepatitis B, indicating immunity from vaccination or past infection. Blood is collected and analysed to determine if booster vaccination is necessary. Healthcare providers use results to guide preventive care and assess risk of infection. Patients benefit by understanding their immune status, preventing hepatitis B, and maintaining long-term liver health through informed vaccination decisions.

This profile evaluates multiple markers for hepatitis B virus, including surface antigen, core antibodies, and e antigen/antibodies. Blood is collected and analysed to determine current infection, immunity, or viral replication. Results guide healthcare providers in treatment planning, vaccination, and monitoring disease progression. Patients benefit from early detection, personalised care, and prevention of liver-related complications, ensuring long-term wellness and informed management of hepatitis B.

This test detects hepatitis B surface antigen, indicating current infection. Blood is collected and analysed to confirm infection status, monitor viral activity, and guide treatment. Early detection allows healthcare providers to prevent liver damage, reduce transmission risk, and monitor therapy effectiveness. Patients benefit by understanding infection status, implementing preventive measures, and protecting long-term liver and overall health.

This test detects antibodies to hepatitis C virus, indicating current or past infection. Blood is collected and analysed to assess exposure and guide further testing for viral RNA if needed. Healthcare providers use results to determine the need for antiviral therapy, monitor disease progression, and prevent liver complications. Patients benefit by understanding their HCV status, receiving timely treatment, and reducing long-term risks of cirrhosis, liver failure, or transmission.

This test detects antibodies to hepatitis C virus, indicating current or past infection. Blood is collected and analysed to assess exposure and guide further testing for viral RNA if needed. Healthcare providers use results to determine the need for antiviral therapy, monitor disease progression, and prevent liver complicatiThis test measures hepatitis C virus RNA in the blood, indicating viral activity and infection severity. Blood is collected and analysed to guide treatment decisions, monitor therapy response, and assess prognosis. Early detection and monitoring allow healthcare providers to adjust antiviral therapy and prevent liver damage. Patients benefit by understanding viral levels, optimising treatment effectiveness, and protecting long-term liver health.ons. Patients benefit by understanding their HCV status, receiving timely treatment, and reducing long-term risks of cirrhosis, liver failure, or transmission.

This test detects antibodies to hepatitis D virus, which can co-infect or super-infect individuals with hepatitis B. Blood is collected and analysed to identify exposure or infection. Early detection allows healthcare providers to guide monitoring, treatment, and preventive measures. Patients benefit by understanding risk, reducing liver complications, and implementing strategies to protect long-term liver function and overall wellness.

This test measures antibodies to hepatitis E virus to detect past (IgG) or recent (IgM) infection. Blood is collected and analysed to assess immunity, active infection, and exposure risk. Healthcare providers use results to guide monitoring, treatment, and preventive measures, especially in vulnerable populations. Patients benefit by understanding infection status, protecting liver health, and taking steps to prevent future HEV-related complications.

The Hepatitis B Core IgM test detects recent or acute Hepatitis B infection by measuring IgM antibodies produced by the immune system. It is especially useful for patients presenting with symptoms like jaundice, fatigue, dark urine, or abdominal discomfort. Detecting IgM antibodies helps healthcare providers differentiate new infections from past exposure or immunity and guides decisions about monitoring and treatment. Blood is drawn via venipuncture, and results are interpreted alongside other hepatitis markers and liver function tests. Understanding your results allows for timely intervention, prevents complications such as liver inflammation, and informs strategies to reduce transmission risk to others.

This test measures IgG antibodies against Herpes Simplex Virus types 1 and 2, which indicate past infection. It helps determine immunity and potential risk for transmission. Patients may be asymptomatic, so testing can identify previous exposure even without symptoms. A blood sample is taken, and results help healthcare providers offer counseling, preventive strategies, and treatment if necessary. Understanding your antibody status can also guide decisions for pregnancy planning or managing recurrent symptoms, supporting both personal and sexual health.
 
This PCR test detects active Herpes Simplex Virus DNA from a swab, confirming current infection. It is highly sensitive and can differentiate between HSV-1 and HSV-2, helping diagnose outbreaks or unexplained lesions. The test is particularly useful in symptomatic individuals or those at risk of transmission. Accurate results allow healthcare providers to prescribe antiviral treatment promptly and provide guidance on preventing spread. PCR testing is essential for early intervention, managing symptoms, and reducing complications associated with HSV infections.
Detects active Herpes Simplex Virus DNA in urine, identifying infection when lesions are not easily accessible. Useful for urinary tract involvement or monitoring viral shedding in asymptomatic patients. Accurate results inform antiviral therapy and infection prevention measures. Blood or urine may be taken depending on symptoms, and results are interpreted alongside clinical presentation.
Measures IgM antibodies to Herpes Simplex Virus types 1 and 2, indicating recent or active infection. Helps differentiate recent outbreaks from past exposure. Patients with new lesions, fever, or discomfort benefit from this test to guide timely treatment and reduce transmission. Blood is drawn for analysis, and results are interpreted alongside clinical history and PCR tests. Understanding IgM results helps patients and healthcare providers make informed decisions about antiviral therapy and precautions.
Measures HIV-1 virus quantity in the blood, monitoring infection severity and treatment effectiveness. Used in newly diagnosed or treated HIV patients to guide therapy adjustments. Accurate viral load assessment helps track disease progression and the risk of transmission. Blood is collected, and results are interpreted alongside CD4 counts and antibody tests. Understanding viral load helps patients and healthcare providers optimise antiretroviral therapy, monitor adherence, and maintain long-term immune health.
This PCR/NAAT panel screens for early HIV, Hepatitis B, and Hepatitis C infection before antibodies are detectable. Ideal for patients with recent exposure or high-risk behaviors. Early detection allows prompt intervention, prevents disease progression, and reduces transmission risk. Blood is drawn, and results are interpreted by specialists. Understanding early infection status empowers patients to make informed healthcare decisions, start treatment if necessary, and adopt preventive measures.
Detects HIV antibodies (I & II) and p24 antigen, allowing early diagnosis of infection. Useful for screening after exposure or as part of routine sexual health checks. Blood is collected via venipuncture, and results are interpreted alongside viral load if positive. Early identification helps guide treatment initiation, reduce viral transmission, and improve long-term health outcomes.
Detects high-risk human papillomavirus (HPV) RNA, associated with cervical and other cancers. Helps identify active infection and guide follow-up screening or preventive care. Samples are usually collected from cervical swabs, and results are interpreted alongside cytology. Early detection of high-risk HPV allows timely intervention, reducing the risk of cancer progression.
Detects antibodies against H. pylori bacteria, a common cause of stomach ulcers and gastritis. A positive result suggests past or current infection, and helps guide treatment to prevent complications such as ulcers or stomach cancer. Blood is collected for testing, and results are interpreted alongside symptoms and other diagnostic tests. Understanding antibody status helps patients and healthcare providers manage infection and prevent gastrointestinal complications.
Detects active H. pylori infection via stool antigen. Helps confirm infection causing gastritis, ulcers, or abdominal discomfort. Useful for diagnosis and post-treatment monitoring. Stool samples are collected at home or clinic, and results guide treatment decisions. Timely identification allows appropriate eradication therapy to prevent complications and improve digestive health.
Detects antibodies to HTLV types 1 and 2, viruses that can cause blood and neurological disorders. Screening is important in at-risk populations or before transfusions. Blood is drawn and analysed, and results guide follow-up testing or counseling. Understanding HTLV status helps prevent transmission and monitor long-term health.
Measures IgG antibodies to HHV-8, associated with Kaposi’s sarcoma or other disorders in immunocompromised patients. Helps identify past infection and assess risk. Blood is drawn, and results are interpreted alongside clinical evaluation. Knowing your HHV-8 status guides monitoring and preventive strategies.
This test detects antibodies to Legionella bacteria, which cause Legionnaires’ disease, a type of pneumonia. Blood is collected and analysed to confirm past or recent infection. Early detection allows healthcare providers to prescribe appropriate antibiotics, monitor recovery, and prevent complications. Patients benefit by receiving timely diagnosis, effective treatment, and guidance to avoid future exposure.
This test detects Legionella antigens in urine, confirming active infection with Legionnaires’ disease. Urine is collected and analysed to identify bacterial proteins. Early detection allows healthcare providers to initiate prompt antibiotic therapy, monitor progress, and prevent severe complications such as respiratory failure. Patients benefit by receiving timely care, reducing disease severity, and ensuring long-term lung health.
This test detects antibodies to Leishmania, a parasite transmitted by sandflies. Blood is collected and analysed to confirm exposure or infection. Early detection allows healthcare providers to initiate treatment, prevent complications, and monitor recovery. Patients benefit by identifying infection risk, receiving timely therapy, and maintaining overall health, particularly in endemic areas.
This test detects IgM antibodies to Leptospira bacteria, which cause leptospirosis, a bacterial infection often acquired through contact with contaminated water or animals. Symptoms can include fever, muscle pain, headache, or jaundice. Early detection allows timely treatment with antibiotics, preventing complications such as kidney or liver damage. Blood is drawn, and results are interpreted alongside clinical symptoms and exposure history. Understanding your leptospirosis status helps healthcare providers manage infection effectively and guide preventive measures, particularly for at-risk individuals such as travelers, farmers, or outdoor workers.
Measures antibodies against Borrelia bacteria, which cause Lyme disease transmitted by tick bites. IgM indicates recent infection, IgG indicates past exposure. Helps confirm diagnosis in patients with fever, rash, or joint pain. Blood is drawn, and results guide treatment and follow-up monitoring. Early detection allows prompt antibiotic therapy and reduces risk of long-term complications such as neurological or joint involvement.
This test detects antibodies against Plasmodium falciparum, the parasite responsible for the most severe form of malaria. Blood is collected to determine whether the patient has been exposed to the parasite, indicating either past infection or immune response. Detecting these antibodies helps healthcare providers confirm previous exposure, assess immunity, and evaluate potential risk for future infection. Early identification allows for preventive counseling, monitoring for complications, and timely intervention if symptoms develop. Patients benefit by understanding their exposure history, reducing anxiety about infection, and supporting informed decisions regarding travel or prophylactic measures. Antibody testing complements diagnostic strategies, guiding healthcare providers in assessing overall malaria risk, planning vaccination or preventive strategies, and optimising long-term health in endemic or post-travel situations.
This test identifies active malaria parasites in the bloodstream using blood samples. The presence, type, and quantity of parasites are determined, which allows healthcare providers to diagnose infection accurately and provide immediate, targeted treatment. Detecting parasites early helps prevent severe complications such as anemia, cerebral malaria, organ dysfunction, and other life-threatening outcomes. Patients benefit by receiving timely therapy, minimising disease severity, and reducing recovery time. This test is especially important for travelers returning from malaria-endemic regions or patients presenting with fever, chills, or fatigue. By confirming parasitic infection, healthcare providers can implement evidence-based interventions, monitor patient progress, and improve long-term health outcomes, ensuring safety and proactive care for at-risk individuals.
This test measures immunity to measles by detecting IgG antibodies in the blood, reflecting either past infection or successful vaccination. Blood is collected and analysed to confirm protective immunity. Results help healthcare providers determine the need for booster vaccinations and prevent potential outbreaks. Patients benefit by understanding their immunity status, ensuring protection against measles, and making informed decisions regarding travel, exposure, or preventive healthcare. Timely assessment reduces the risk of infection, supports public health measures, and allows individuals to maintain long-term wellness and immunity to serious viral diseases
This test measures antibodies to meningococcal bacteria, evaluating immune protection against meningococcal disease. Blood is drawn and analysed to confirm vaccination efficacy or prior exposure. Results help healthcare providers recommend booster vaccinations, preventive strategies, and public health guidance. Patients benefit by understanding their immune status, preventing infection, and reducing risk of life-threatening complications such as meningitis or septicemia. This testing supports proactive health decisions, ensuring long-term protection and overall wellness against serious bacterial infections.
This rapid PCR test detects MRSA colonization in the groin. Swabs are collected and analysed to identify methicillin-resistant Staphylococcus aureus. Early identification allows healthcare providers to implement infection control measures, guide treatment, and prevent serious infections. Patients benefit by reducing risk of severe skin, soft tissue, or systemic infections, maintaining overall health, and protecting household or hospital contacts. Timely testing supports proactive infection management and long-term wellness.
This rapid PCR test detects MRSA colonization in the nasal passages. Swabs are collected and analysed to identify methicillin-resistant Staphylococcus aureus. Early detection allows healthcare providers to implement preventive measures, reduce transmission risk, and guide timely treatment. Patients benefit by maintaining health, preventing infection, and supporting long-term wellness.
This test measures IgG antibodies against mumps virus, confirming immunity from past infection or vaccination. Blood is collected and analysed to ensure protection and determine the need for booster vaccinations. Results guide healthcare providers in preventive care planning. Patients benefit by confirming immunity, reducing the risk of infection, and protecting long-term health. Timely testing supports informed health decisions and proactive preventive measures.
This test measures IgM antibodies against mumps virus to detect current or recent infection. Blood is drawn and analysed to confirm active infection. Early detection allows healthcare providers to manage symptoms, prevent transmission, and monitor recovery. Patients benefit by understanding infection status, implementing precautions, and reducing the risk of complications such as orchitis or meningitis. Prompt diagnosis supports timely care and overall wellness.
This test analyses nail clippings to assess exposure to heavy metals, toxins, and essential trace elements over time. Nail tissue can reflect long-term environmental and occupational exposures, including lead, mercury, and arsenic. Collected clippings are analysed in a laboratory to detect accumulation of these substances, which may affect organ function, neurological health, or metabolic balance. Results allow healthcare providers to identify chronic exposures, recommend dietary or lifestyle interventions, and monitor patient progress. Patients benefit by understanding potential toxin burdens, implementing preventive measures, and supporting overall wellness. Nail analysis provides a non-invasive, longitudinal view of exposure that complements other clinical assessments, helping patients maintain optimal health and reduce long-term risk of organ or neurological damage.
This test measures parvovirus IgG and IgM antibodies to detect past or recent infection. Blood is collected and analysed to determine immunity or active infection. Early identification helps healthcare providers monitor symptoms, provide treatment guidance, and implement preventive measures. Patients benefit by understanding infection status, ensuring immunity, reducing the risk of complications during pregnancy, and supporting overall health. Timely assessment enables informed healthcare decisions and proactive interventions.
This test detects heterophile antibodies associated with mononucleosis (Monospot). Blood is collected and analysed to confirm infection with Epstein-Barr virus. Early detection allows healthcare providers to manage symptoms, prevent complications, and provide guidance for recovery. Patients benefit by understanding infection status, receiving supportive care, and minimising the risk of transmission. Timely diagnosis supports informed care, symptom management, and overall wellness.
This test screens for atypical pneumonia pathogens using blood or respiratory samples. Analysis identifies bacterial or viral infections causing pneumonia symptoms. Early identification allows healthcare providers to implement targeted treatment, monitor recovery, and prevent complications. Patients benefit by receiving timely therapy, reducing illness severity, and maintaining respiratory and overall health. Screening improves early diagnosis, supports appropriate care, and promotes long-term wellness.
This test detects antibodies to Q fever (Coxiella burnetii), a bacterial infection that can cause flu-like illness, hepatitis, or endocarditis. Blood is collected and analysed to confirm exposure or active infection. Early detection allows healthcare providers to implement antibiotic therapy, monitor recovery, and prevent complications. Patients benefit by understanding infection status, managing illness effectively, and protecting long-term health. Timely testing supports informed healthcare decisions and preventive strategies.
This test measures rabies antibodies to assess immunity following vaccination or exposure. Blood is collected and analysed to confirm protective antibody levels. Results help healthcare providers determine the need for booster vaccinations and monitor immune response. Patients benefit by understanding rabies protection, preventing infection, and ensuring long-term health. Timely assessment supports preventive care and informed decision-making.
This test detects antibodies against Rickettsial species, a group of bacteria that can cause diseases such as spotted fever and typhus. Blood is collected and analysed to determine exposure or active infection. Early detection allows healthcare providers to prescribe targeted antibiotic therapy, monitor recovery, and prevent complications such as organ damage or severe systemic illness. Patients benefit by understanding infection risk, receiving timely care, and reducing the severity of illness. Regular testing is especially important for individuals with travel to endemic areas or exposure to vectors like ticks and fleas. Timely detection and monitoring ensure long-term wellness and effective management of potential Rickettsial infections.
This test detects rotavirus in stool samples using PCR technology to identify viral genetic material. Stool is collected and analysed to confirm infection, which is a common cause of severe gastroenteritis in children and adults. Early detection allows healthcare providers to implement hydration therapy, symptom management, and infection control measures. Patients benefit by understanding the cause of gastrointestinal symptoms, preventing dehydration, reducing transmission risk, and supporting recovery. Accurate identification of rotavirus infection helps guide treatment decisions, prevent complications, and maintain overall gastrointestinal and general health.
This test measures rubella IgG antibodies in blood to determine immunity from past infection or vaccination. Blood is collected and analysed to confirm protective antibody levels. Results help healthcare providers determine the need for booster vaccinations and provide guidance on reproductive health, particularly for women of childbearing age. Patients benefit by confirming immunity, reducing the risk of infection during pregnancy, and supporting long-term health. Timely assessment ensures effective preventive care, protects fetal health, and contributes to overall wellness. Monitoring immunity helps prevent outbreaks and provides reassurance regarding personal and public health protection.
This test measures rubella IgM antibodies to detect recent or current infection. Blood is collected and analysed to confirm active infection, which can be particularly important during pregnancy. Early detection allows healthcare providers to implement monitoring, counseling, and preventive measures to protect maternal and fetal health. Patients benefit by understanding infection status, receiving timely guidance, and reducing the risk of complications. Accurate and prompt detection supports informed decisions, preventive strategies, and overall wellness.
This stool test detects ova, cysts, and parasites to identify intestinal infections. Stool is collected and analysed to detect pathogens such as Giardia, Entamoeba, or helminths. Early detection allows healthcare providers to prescribe targeted treatment, prevent complications, and reduce transmission. Patients benefit by identifying infections promptly, receiving appropriate therapy, and maintaining digestive and overall health. Timely diagnosis supports informed care and long-term wellness.
This test detects Strongyloides antibodies, a parasitic infection that can persist chronically. Blood is collected and analysed to determine exposure or infection. Early detection allows healthcare providers to initiate appropriate treatment, prevent complications such as hyperinfection, and monitor recovery. Patients benefit by understanding infection risk, receiving timely therapy, and protecting long-term health. Timely assessment supports informed care and proactive management of parasitic infections.
This test analyses cervical swabs to detect infections, cellular abnormalities, or HPV presence. Samples are collected and analysed to identify bacterial, viral, or precancerous changes. Early detection allows healthcare providers to guide treatment, monitor progression, and prevent complications such as cervical cancer. Patients benefit by understanding cervical health, implementing preventive strategies, and supporting long-term reproductive wellness. Timely testing enables early intervention and overall wellness.
This test analyses eye swabs to detect bacterial or viral infections affecting ocular health. Swabs are collected and analysed to identify pathogens, guide treatment, and prevent complications such as keratitis or conjunctivitis. Patients benefit by understanding eye health status, receiving timely therapy, and maintaining vision and overall wellness. Early detection supports proactive care and informed management.
This test analyses swabs from any site of the body to detect bacterial, fungal, or viral infections. Samples are collected and cultured in a laboratory to identify pathogens accurately. Early detection allows healthcare providers to prescribe targeted treatment, monitor recovery, and prevent complications. Patients benefit by understanding infection status, receiving timely therapy, and maintaining long-term health. Testing supports proper diagnosis, reduces the risk of spreading infections, and promotes overall wellness. Accurate culture results also guide future preventive strategies, ensuring optimal care and reducing potential complications.
This test analyses nasal swabs to detect bacterial, viral, or fungal infections. Samples are collected and analysed to confirm infection, guide treatment, and monitor patient recovery. Early detection allows healthcare providers to recommend targeted interventions and preventive measures. Patients benefit by understanding nasal and respiratory health, managing symptoms proactively, and preventing complications. Timely testing ensures appropriate therapy, reduces transmission risk, and supports overall wellness. Accurate nasal swab analysis helps maintain respiratory and general health.
This test analyses oral swabs to detect bacterial, viral, or fungal infections affecting the mouth or throat. Samples are collected and cultured to identify pathogens, guide treatment, and monitor recovery. Early detection allows healthcare providers to implement targeted interventions, prevent complications, and reduce transmission. Patients benefit by understanding oral health status, receiving appropriate care, and supporting long-term wellness. Timely testing promotes informed health decisions, reduces symptom severity, and maintains oral and systemic health.
This test analyses penile swabs to detect sexually transmitted infections (STIs) such as chlamydia or gonorrhea. Swabs are collected and analysed to identify pathogens accurately. Early detection allows healthcare providers to implement targeted therapy, prevent complications, and reduce transmission to partners. Patients benefit by understanding infection status, receiving timely treatment, and maintaining sexual and reproductive health. Accurate testing supports informed decisions, reduces long-term health risks, and promotes overall wellness.
This test analyses oral swabs to detect bacterial, viral, or fungal infections affecting the mouth or throat. Samples are collected and cultured to identify pathogens, guide treatment, and monitor recovery. Early detection allows healthcare providers to implement targeted interventions, prevent complications, and reduce transmission. Patients benefit by understanding oral health status, receiving appropriate care, and supporting long-term wellness. Timely testing promotes informed health decisions, reduces symptom severity, and maintains oral and systemic health.
This test analyses skin swabs to detect bacterial, fungal, or viral infections affecting the skin. Swabs are collected and cultured to identify pathogens accurately. Early detection allows healthcare providers to guide treatment, monitor healing, and prevent complications. Patients benefit by understanding skin health, receiving timely therapy, reducing spread, and supporting long-term wellness. Accurate swab analysis informs preventive care, supports rapid recovery, and maintains overall health.
This test analyses throat swabs to detect bacterial, viral, or fungal infections such as strep throat. Samples are collected and cultured to identify pathogens accurately. Early detection allows healthcare providers to recommend targeted therapy, monitor recovery, and prevent complications. Patients benefit by understanding throat health, managing symptoms proactively, and supporting long-term wellness. Timely testing reduces transmission risk and ensures appropriate care, promoting optimal oral and systemic health.
This test analyses vulval swabs to detect infections including bacterial, viral, or fungal pathogens. Samples are collected and cultured to identify causative organisms. Early detection allows healthcare providers to implement treatment, prevent complications, and reduce transmission. Patients benefit by understanding vulval health, receiving timely care, and maintaining reproductive and overall wellness. Accurate testing supports informed decisions, symptom management, and long-term health outcomes.
This test analyses wound swabs to detect bacterial, viral, or fungal infections in wounds, surgical sites, or injuries. Samples are collected and cultured to identify pathogens accurately. Early detection allows healthcare providers to prescribe targeted therapy, prevent infection spread, and monitor healing. Patients benefit by understanding wound health, reducing risk of complications, and supporting long-term wellness. Timely testing ensures proper infection control, optimal recovery, and overall health maintenance.
This test measures antibodies for syphilis (IgG/IgM) to detect current or past infection. Blood is collected and analysed to guide treatment, monitor recovery, and prevent transmission. Early detection allows healthcare providers to prescribe antibiotics, prevent complications such as neurological or cardiovascular involvement, and ensure follow-up care. Patients benefit by understanding infection status, receiving timely therapy, reducing risk of long-term complications, and maintaining sexual and overall health. Accurate testing supports informed decisions and preventive measures.
This test measures immune response to tuberculosis using the Quantiferon-TB Gold assay. Blood is collected to detect latent or active TB infection by measuring interferon-gamma release. Early detection allows healthcare providers to initiate treatment, prevent active disease, and reduce transmission. Patients benefit by understanding TB exposure, receiving timely interventions, and protecting long-term respiratory and overall health. Accurate testing supports informed decisions, preventive care, and public health safety.
This test measures tetanus antibodies in blood to determine immunity following vaccination or exposure. Blood is collected and analysed to assess protective antibody levels. Results help healthcare providers recommend booster doses if needed, ensuring continued protection against tetanus. Patients benefit by understanding immunity status, preventing infection, and supporting long-term health. Timely assessment ensures preventive care, informed decision-making, and overall wellness.
This test detects toxoplasma antibodies (IgG and IgM) to determine past or recent infection. Blood is collected and analysed to assess immune status and guide pregnancy or immunocompromised care. Early detection allows healthcare providers to monitor infection, recommend interventions, and prevent complications such as congenital transmission. Patients benefit by understanding infection risk, receiving timely guidance, and supporting long-term health. Timely testing ensures proactive care, informed decisions, and overall wellness.
This test measures Treponema pallidum particle agglutination (TPPA) antibodies to detect syphilis infection. Blood is collected and analysed to confirm past or current infection. Early detection allows healthcare providers to implement antibiotic therapy, monitor disease progression, and prevent complications. Patients benefit by understanding infection status, receiving timely treatment, reducing long-term risks, and maintaining sexual and overall health. Accurate testing supports informed healthcare decisions and preventive strategies.
This test analyses urine microscopy and culture to detect urinary tract infections, kidney disorders, or abnormal cellular components. Urine is collected and examined to identify pathogens or abnormalities. Early detection allows healthcare providers to guide treatment, monitor recovery, and prevent complications. Patients benefit by understanding urinary health, receiving timely care, and supporting long-term wellness. Accurate testing supports informed decisions, infection prevention, and overall health maintenance.
This test analyses vaginal swabs to detect bacterial, viral, or fungal infections, including STIs. Samples are collected and cultured to identify pathogens accurately. Early detection allows healthcare providers to implement treatment, monitor recovery, and prevent complications. Patients benefit by understanding vaginal health, reducing infection risks, and supporting reproductive and overall wellness. Timely testing ensures informed decisions, preventive care, and long-term health maintenance.

This test measures VZV IgG antibodies to confirm immunity to chickenpox or shingles. Blood is collected and analysed to determine if protective levels are present. Results help healthcare providers recommend vaccination or booster doses if needed. Patients benefit by understanding immunity status, preventing infection, and supporting long-term health. Timely testing ensures proactive preventive care and informed healthcare decisions.

This test measures VZV IgG antibodies to confirm immunity to chickenpox or shingles. Blood is collected and analysed to determine if protective levels are present. Results help healthcare providers recommend vaccination or booster doses if needed. Patients benefit by understanding immunity status, preventing infection, and supporting long-term health. Timely testing ensures proactive preventive care and informed healthcare decisions.

This test measures antibodies to respiratory viruses to screen for viral respiratory infections. Blood or swabs are collected and analysed to detect pathogens such as influenza, RSV, or adenovirus. Early detection allows healthcare providers to implement appropriate therapy, monitor recovery, and prevent complications. Patients benefit by understanding infection status, receiving timely care, reducing severity, and supporting overall health. Accurate testing informs preventive strategies and long-term wellness.

This test measures antibodies against pertussis (whooping cough) to evaluate immunity or past infection. Blood is collected and analysed to determine whether protective antibody levels are present. Results help healthcare providers assess immunity, recommend booster vaccination if needed, and reduce risk of infection. Patients benefit by understanding protection status, preventing disease, and supporting long-term respiratory health. Timely testing ensures informed preventive care and wellness.

This test measures antibodies against yellow fever virus to confirm immunity or previous exposure. Blood is collected and analysed to determine protective antibody levels. Results help healthcare providers assess vaccination efficacy, guide booster recommendations, and prevent infection. Patients benefit by understanding immunity status, reducing infection risk, and supporting long-term health, particularly when traveling to endemic areas. Timely assessment ensures effective preventive care and wellness.

This test measures antibodies against Yersinia bacteria, which can cause gastrointestinal infections. Blood is collected and analysed to detect past or current infection. Early identification allows healthcare providers to guide treatment, monitor recovery, and prevent complications. Patients benefit by understanding exposure status, implementing preventive measures, and maintaining long-term gastrointestinal and overall health. Timely testing supports informed healthcare decisions and proactive management.

This test detects Zika virus IgM and IgG antibodies to assess recent or past infection. Blood is collected and analysed to determine immunity or current exposure, particularly important for pregnant women. Early detection allows healthcare providers to implement preventive measures, monitor complications, and provide counseling. Patients benefit by understanding infection risk, taking timely action, and supporting long-term reproductive and general health. Accurate testing ensures proactive care and overall wellness.

Safeguard your health with accurate infection testing and confidential results from Bids Chemist.

Book An Appointment